You have 9 free searches left this month | for more free features.

RR MM

Showing 1 - 25 of 3,942

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Myeloma Trial in Xuzhou (anti-BCMA/GPRC5D CAR-T CELL)

Recruiting
  • Multiple Myeloma
  • anti-BCMA/GPRC5D CAR-T CELL
  • Xuzhou, Jiangsu, China
    Kailin Xu
Aug 19, 2022

Carfilzomib in Combination for the Treatment of RR MM

Unknown status
  • Multiple Myeloma
  • +2 more
  • Samsun, Turkey
    19 Mayıs University Faculty of Medicine
Jun 27, 2019

Diabetes, Type 2 Trial (Magnetic mitohormesis)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Magnetic mitohormesis
  • (no location specified)
May 30, 2023

Multiple Myeloma, Amyloidosis Trial in Jacksonville, New York, Cleveland (APG-2575+ Pd, APG-2575 + DRd)

Recruiting
  • Multiple Myeloma
  • Amyloidosis
  • APG-2575+ Pd
  • APG-2575 + DRd
  • Jacksonville, Florida
  • +2 more
Feb 28, 2022

Immunotherapy, Multiple Myeloma Trial in Zhengzhou (Chimeric Antigen Receptor NK Cell Injection Targeting BCMA (BCMA CAR-NK))

Recruiting
  • Immunotherapy
  • Multiple Myeloma
  • Chimeric Antigen Receptor NK Cell Injection Targeting BCMA (BCMA CAR-NK)
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Dec 14, 2022

Multiple Myeloma Trial in New Haven (Elotuzumab, Belantamab mafodotin)

Recruiting
  • Multiple Myeloma
  • New Haven, Connecticut
    Yale New Haven Hospital
Aug 15, 2022

Heart Rate and Respiratory Rate for Heart Failure

Recruiting
  • Heart Failure
  • +2 more
  • WHOOP strap 3.0
  • Hershey, Pennsylvania
    Penn State Hershey Medical Center
Nov 23, 2021

Acute Respiratory Distress Syndrome Trial in Boston (ASV, Lung Protective Ventilation)

Completed
  • Acute Respiratory Distress Syndrome
  • ASV
  • Lung Protective Ventilation
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Mar 7, 2022

Fluoroquinolone Resistance Prevalence Study

Recruiting
  • Multiple Myeloma
    • Washington, District of Columbia
    • +1 more
    Apr 10, 2023

    Coronary Artery Disease, Heart Failure Systolic Trial (Revascularization by PCI, Revascularization by CABG)

    Not yet recruiting
    • Coronary Artery Disease
    • Heart Failure Systolic
    • Revascularization by PCI
    • Revascularization by CABG
    • (no location specified)
    Jul 13, 2022

    89Zr-Bevacizumab PET/CT Imaging in NF2 Patients

    Recruiting
    • Neurofibromatosis 2
    • Bevacizumab Zirconium Zr-89
    • Leiden, Zuid-Holland, Netherlands
      Leiden University Medical Center
    Jan 5, 2023

    Varicose Veins, Dilated Veins Trial in Arnhem (Mechano-chemical ablation)

    Completed
    • Varicose Veins
    • Dilated Veins
    • Mechano-chemical ablation
    • Arnhem, Gelderland, Netherlands
      Rijnstate Hospital
    Apr 26, 2022

    Liquid Biopsy With PET/CT Versus PET/CT Alone in Diagnosis of

    Recruiting
    • Lung Cancer
    • +2 more
      • Palo Alto, California
        VA Palo Alto Health Care System
      Oct 6, 2022

      Patterns and Disease Control in cHL and sALCL in Routine

      Completed
      • Hodgkin Disease
      • Lymphoma, Large-cell, Anaplastic
        • Astrakhan, Russian Federation
        • +49 more
        Dec 19, 2022

        Paroxysmal Atrial Fibrillation Trial (cryoablation of atrial fibrillation using only 28 mm size balloon, cryoablation of atrial

        Not yet recruiting
        • Paroxysmal Atrial Fibrillation
        • cryoablation of atrial fibrillation using only 28 mm size balloon
        • cryoablation of atrial fibrillation using expandable balloon (28 / 31 mm)
        • (no location specified)
        Sep 23, 2023

        Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis Trial in China (Bedaquiline, Delamanid, Contezolid)

        Not yet recruiting
        • Pulmonary Tuberculosis
        • Rifampicin-resistant Tuberculosis
        • Beijing, Beijing, China
        • +37 more
        Oct 11, 2023

        Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Phoenix, Jacksonville, Rochester

        Recruiting
        • Plasma Cell Myeloma
        • +3 more
        • Bone Marrow Biopsy
        • +3 more
        • Phoenix, Arizona
        • +2 more
        Jan 18, 2023

        Multiple Myeloma Trial in Beijing, Suzhou (CAR-BCMA T Cells)

        Recruiting
        • Multiple Myeloma
        • CAR-BCMA T Cells
        • Beijing, Beijing, China
        • +1 more
        Jan 26, 2023

        Respiration Rate, Heart Rate Trial (VSC-MEDlib)

        Not yet recruiting
        • Respiration Rate
        • Heart Rate
        • VSC-MEDlib
        • (no location specified)
        Nov 16, 2023

        Surgery--Complications Trial in Paris, Suresnes (Biobeat patch)

        Recruiting
        • Surgery--Complications
        • Biobeat patch
        • Paris, France
        • +1 more
        Jan 12, 2022

        Tuberculosis, Multidrug-Resistant Trial (Amikacin)

        Not yet recruiting
        • Tuberculosis, Multidrug-Resistant
        • (no location specified)
        Sep 23, 2022

        Multiple Sclerosis, Relapsing-Remitting Trial in Chisinau (IMCY-0141, Placebo, Dimethyl Fumarate)

        Recruiting
        • Multiple Sclerosis, Relapsing-Remitting
        • Chisinau, Moldova, Republic of
          Republican Clinical Hospital, ARENSIA Exploratory Medicine
        Jun 8, 2022

        Multiple Myeloma Trial in United States (Elotuzumab, Pomalidomide, Carfilzomib)

        Terminated
        • Multiple Myeloma
        • Encinitas, California
        • +5 more
        Mar 15, 2022

        Normoglycemia, T2DM (Type 2 Diabetes) Trial in New Delhi (Bread, Mango)

        Completed
        • Normoglycemia
        • T2DM (Type 2 Diabetes Mellitus)
        • Bread
        • Mango
        • New Delhi, Delhi, India
          Fortis CDOC Hospital
        Sep 20, 2023